active taVNS for Infant Feeding Problems
This trial will test a new system that stimulates the vagus nerve to see if it helps pre-term infants and infants with brain injury to be able to eat and avoid a feeding tube.
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Find a site
Who is running the clinical trial?
Frequently Asked Questions
How many participants have enrolled in this experiment?
"Affirmative. The clinical trial registry displays that this medical experiment, initially advertised on August 1st 2022, is currently recruiting subjects. It seeks 20 volunteers from a single site."
Am I eligible to join this clinical experiment?
"To be considered for this research study, applicants must have a medical diagnosis of brain ischemia and fall within the 2 week to 5 month age range. As of now, there are 20 open spots available."
Are there ongoing opportunities for volunteers to partake in the trial?
"As stated on clinicaltrials.gov, this research is currently recruiting candidates with the initial posting date of August 1st 2022 and most recent edits made just two days ago."
Has transcutaneous vagus nerve stimulation obtained FDA authorization?
"The safety of taVNS is ranked a 1 on our evaluation scale given that this particular trial has only produced limited data regarding efficacy and security."
Is this experimental research enrolling individuals aged 40 or above?
"The trial is open to children between 2 weeks and 5 months of age."